Updated: BioSpace's List of December 2018 Life Sciences IPOs
December 2018 IPO Filings and Proceeds, Updated 12/28/18
Know of an IPO since Dec. 1, 2018 that we missed? Email us at email@example.com.
Related: Check out BioSpace's October IPO list here and November list here.
|Date||Company Name||Amount (USD)||Company HQ||Research Focus|
|12/28/18||Stealth Biotherapeutics||$86.3M Filed||Newton, MA||Novel therapies for diseases involving mitochondrial dysfunction|
|12/28/18||TCR2 Therapeutics||$100M Filed||Cambridge, MA||Novel T-cell therapies using multi-format TRuC platform|
|12/27/18||Harpoon Therapeutics||$86.3M Filed||San Francisco, CA||T cell engagers that harness the immune system to treat cancer and other diseases|
|12/21/18||Gossamer Bio||$264.5M Filed||San Diego, CA||Therapeutics in the disease areas of immunology, inflammation, and oncology|
|12/21/18||Hoverink Biotechnologies||$40M Filed||Los Angeles, CA||Opioid alternatives for GI and oncological diseases|
|12/11/18||Cannabinoid Biosciences||$50M Filed||Los Angeles, CA||Cannabinoid-based products for a wide range of diseases|
|12/7/18||DiaMedica||$16.4M Priced||Minneapolis, MN||DM199, a recombinant human protein, for neurological and kidney diseases|
|12/7/18||Synthorx||$131M Priced||La Jolla, CA||Designing and building protein therapeutics to treat cancer and autoimmune disorders|
|12/6/18||Moderna||$604.3M Priced||Cambridge, MA||mRNA medicines used to eventually prevent, treat, or cure disease|
|12/6/18||Aptorum Group||$30M Priced||Hong Kong||Preclinical pharmaceutical company across a wide range of disease areas|